Page 35

Bioenergy no 5 September 2015

Busines Guide • Chain conveyors • Screw conveyors • Port terminals • Bucket elevators • Intake systems • Truck loading systems • Belt conveyors • Dust aspiration systems • Storage systems Let’s test your raw material - and offer you a briquetting solution erik@bruzabruk.se www.bruzabruk.se Bioenergy International No 81, 5-2015 2015 35 Torpängsvägen 2, SE-148 60 Stora Vika +46 (0)8-10 99 15 +46 (0)739-823 066 info@fbio.se www.firstbioenergy.se Turn your WASTE into PROFIT… Turn your wastewood and other biomass into valuable fuel briquettes www.cfnielsen.com – Market Leader for 70 years… Customized Gratebars Reduce your CO2 footprint, buy from Sweden ! Bulk handling technology for biomass fuels www.lachenmeier-monsun.com • Biomas Boilers • ORC Cogeneration • Turn-Key Plants Gevo and Butamax bury icy-butanol battleaxes US based advanced biofuel technology development companies Gevo, Inc., and Butamax Advanced Biofuels LLC – a joint venture between BP and DuPont – have announced that they have entered into global patent cross-license and settlement agreements, ending a patent dispute related to technologies for the production of bio-based isobutanol. This settlement ends all of the previous lawsuits and creates a new relationship between the companies. The cross-license agreement grants both parties patent licenses to all fields for isobutanol and is structured to develop robust and sustainable isobutanol markets. The license will be royalty bearing for Butamax in certain fields and royalty bearing for Gevo in other fields. There are also a number of fields that are royalty-free for both companies. Both parties can sell up to 30 million gallons per year royalty-free into any field. Butamax will take the lead role in developing the market for isobutanol as an on-road gasoline blendstock. In parallel, Gevo will lead development of the jet fuel market. Gevo has been producing and selling alcohol-to-jet fuel (ATJ) derived from isobutanol since 2011. While Butamax and Gevo have cross-licensed all of their patents for making and using isobutanol, both parties will have their own biocatalyst and process technologies and are free to license their respective technology packages to third parties. A third party licensee would be granted a sub-license, and would be subject to terms and conditions that are consistent with the cross-license between Butamax and Gevo. Both parties have agreed to keep all other details not required by law to be disclosed relating to these agreements confidential. BI81/4996/AS


Bioenergy no 5 September 2015
To see the actual publication please follow the link above